- Price
- $37.15
- Day
- -1.33%
- Mkt Cap
- $1.69B
- 52W Range
- $29.06 – $55.00
- Volume
- 1.14M
- Beta
- 0.97
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Dimensional Fund Advisors LP raised its holdings in Omnicell, Inc. (NASDAQ: OMCL) by 6.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,450,385 shares of the company's stock after purchasing an additional 137,834 shares during the period. Dimensional Fund Advisors LP
Read full article
On July 31, 2026, Omnicell Inc (OMCL) shares fell 4.7% today, bringing the current price to $35.37. The stock has experienced significant fluctuations over the
Read full article
Omnicell highlights Titan XT and OmniSphere momentum, and raises profit outlook, while customer approval timing weighs on product bookings.
Read full article
Omnicell, Inc. (OMCL) Q2 2026 Earnings Call Transcript
Read full article
FORT WORTH, Texas--(BUSINESS WIRE)--EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination.
Read full article
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Second Quarter 2026 Financial Results.
Read full article
Omnicell NASDAQ: OMCL reported second-quarter 2026 revenue at the high end of its prior outlook and profitability above expectations, while widening its full-year product bookings range to reflect uncertainty in the timing of customer purchasing decisions for large medication-management platform investments.
Read full article
Omnicell (OMCL) came out with quarterly earnings of $0.94 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.45 per share a year ago.
Read full article
OMCL heads into Q2 earnings with OmniSphere adoption, Connected Devices execution and recurring revenue growth ahead of July 30 results.
Read full article